StockSelector.com
  Research, Select, & Monitor Tuesday, November 21, 2017 8:28:03 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Bristol-Myers Squibb Co.$60.80($.52)(.85%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Bristol-Myers Squibb Co. has an overall rank of 2831 out of 7206 stocks based on 12 positive rankings and 9 negative rankings.

Positive Rankings
Top Intrinsic Values
Bristol-Myers Squibb Co. rank is 311
Highest ROA
Bristol-Myers Squibb Co. rank is 321
Highest ROE
Bristol-Myers Squibb Co. rank is 394
PEGValue
Bristol-Myers Squibb Co. has a PEG Value of $76.92. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 26.51% in the next year. Among companies with a PEG Value above the current stock price, Bristol-Myers Squibb Co. is ranked 506.
Highest Net Margin
Bristol-Myers Squibb Co. rank is 564
SSValue
The StockSelector Value for Bristol-Myers Squibb Co. is $88.80. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Bristol-Myers Squibb Co. is ranked 629.
Top Industry Values
Bristol-Myers Squibb Co. rank is 944
Estimated EPS Growth
Bristol-Myers Squibb Co. rank is 1123
90 Day Gain
Bristol-Myers Squibb Co. rank is 1342
Historic EPS Growth
Bristol-Myers Squibb Co. rank is 1440
Estimated Revenue Growth
Bristol-Myers Squibb Co. rank is 1550
Debt-to-Equity
Bristol-Myers Squibb Co. rank is 2160
Negative Rankings
Down EPS Surprise
Bristol-Myers Squibb Co. missed the consensus earnings estimate when it last reported quarterly earnings.
Missed Whisper
According to EarningsWhispers.com, Bristol-Myers Squibb Co. missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Price-to-Book
Bristol-Myers Squibb Co. rank is 760
High Put/Call
Bristol-Myers Squibb Co. has a high Put/Call ratio of 0.99 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 1024.
Price-to-Sales
Bristol-Myers Squibb Co. rank is 1123
Negative Revenue Growth
Bristol-Myers Squibb Co. rank is 1244
Negative Cash Growth
Bristol-Myers Squibb Co. rank is 1437
10 Day Loss
Bristol-Myers Squibb Co. rank is 1715
High vPut/Call
Bristol-Myers Squibb Co. has a high Put/Call ratio of 0.50 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 2031.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.